Assignee
THERATECHNOLOGIES INC
CA·22 granted patents·10 pending applications·2,689 citations·filing 1993–2022
Top patents by PatentIndex Score
32 records- 0196US5561275AHeadset for electronic stethoscopeTHERATECHNOLOGIES INC.·Filed 1994·Granted Oct 1, 1996·942 cites·9 claims
- 0290US5834418AProcess for the preparation of platelet growth factors extractTHERATECHNOLOGIES INC·Filed 1996·Granted Nov 10, 1998·139 cites·8 claims
- 0389US5602924AElectronic stethescopeTHERATECHNOLOGIES INC·Filed 1993·Granted Feb 11, 1997·1.2k cites·6 claims
- 0486US7316997B2GH secretagogues and uses thereofTHERATECHNOLOGIES INC·Filed 2004·Granted Jan 8, 2008·21 cites·8 claims
- 0584US7094761B2Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditionsTHERATECHNOLOGIES INC·Filed 2004·Granted Aug 22, 2006·10 cites·31 claims
- 0683US8361964B2Growth hormone releasing factor (GRF) analogs and uses thereofTHERATECHNOLOGIES INC·Filed 2012·Granted Jan 29, 2013·3 cites·30 claims
- 0778US7893025B2Use of growth hormone releasing factor analogs in treating patients suffering from wastingTHERATECHNOLOGIES INC·Filed 2004·Granted Feb 22, 2011·14 cites·12 claims
- 0878US7067488B2Modified GLP-1 peptides with increased biological potencyTHERATECHNOLOGIES INC·Filed 2003·Granted Jun 27, 2006·5 cites·23 claims
- 0978US6864239B2Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditionsTHERATECHNOLOGIES INC·Filed 2003·Granted Mar 8, 2005·14 cites·29 claims
- 1075US5861379AChimeric fatty body-pro-GRF analogs with increased biological potencyTHERATECHNOLOGIES INC·Filed 1996·Granted Jan 19, 1999·35 cites·17 claims
- 1174US5939386AChimeric fatty body-pro-GRF (1-29) analogs with increased biological potencyTHERATECHNOLOGIES INC·Filed 1996·Granted Aug 17, 1999·33 cites·16 claims
- 1272US6458764B1GRF analogs with increased biological potencyTHERATECHNOLOGIES INC·Filed 1999·Granted Oct 1, 2002·29 cites·10 claims
- 1368US6020311AGRF analogs with increased biological potencyTHERATECHNOLOGIES INC·Filed 1998·Granted Feb 1, 2000·32 cites·10 claims
- 1466US6106544ACutaneous harness for sutureless wound closingTHERATECHNOLOGIES INC·Filed 1998·Granted Aug 22, 2000·114 cites·28 claims
- 1564US7414029B2Antagonistic peptides of prostaglandin E2 receptor subtype EP4THERATECHNOLOGIES INC·Filed 2004·Granted Aug 19, 2008·3 cites·13 claims
- 1664US6194384B1Long-acting galenical formulation for GRF peptidesTHERATECHNOLOGIES INC·Filed 1998·Granted Feb 27, 2001·22 cites·12 claims
- 1764US2022378880A1Pharmaceutical compositions of ghrh analogs and uses thereofTHERATECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1860US2021322519A1Pharmaceutical compositions of ghrh analogs and uses thereofTHERATECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1959US2020297817A1Pharmaceutical compositions of ghrh analogs and uses thereofTHERATECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 2057US5843123ACutaneous harness for sutureless wound closingTHERATECHNOLOGIES INC·Filed 1996·Granted Dec 1, 1998·74 cites·23 claims
- 2156US2006292613A1Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditionsTHERATECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 2250US9334314B2Peptide compounds derived from melanotransferrin and uses thereofTHERATECHNOLOGIES INC·Filed 2012·Granted May 10, 2016·0 cites·9 claims
- 2350US8871713B2Formulations of growth hormone releasing factor (GRF) molecules with improved stabilityTHERATECHNOLOGIES INC·Filed 2013·Granted Oct 28, 2014·0 cites·23 claims
- 2450US2023036041A1Sortilin binding conjugate compounds, compositions and uses thereof for treating cancerTHERATECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2548US2008249017A1Pharmaceutical formulations of ghrh moleculesTHERATECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 2647US2004171534A1GRF analogs with increased biological potencyTHERATECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 2744US2023270865A1Low-dose pharmaceutical compositions of ghrh analogs and uses thereofTHERATECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2844US2010267636A1Use of cytochrome p450-metabolized drugs and grf molecules in combination therapyTHERATECHNOLOGIES INC·Filed 2010·Application pending·0 cites
- 2942US2011105390A1Selection and treatment of patients suffering from wastingTHERATECHNOLOGIES INC·Filed 2011·Application pending·0 cites
- 3040US7538185B2Glucagon-like peptide-1 analogs with long duration of actionTHERATECHNOLOGIES INC·Filed 2005·Granted May 26, 2009·0 cites·32 claims
- 3134US5798523AIrradiating apparatus using a scanning light source for photodynamic treatmentTHERATECHNOLOGIES INC·Filed 1996·Granted Aug 25, 1998·29 cites·13 claims
- 3233US5817627ALong-acting galenical formulation for GRF peptidesTHERATECHNOLOGIES INC·Filed 1996·Granted Oct 6, 1998·1 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when THERATECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →